FR2780886A1 - Topical cosmetic composition useful for treatment of dry skin by renewal of stratum corneum - Google Patents
Topical cosmetic composition useful for treatment of dry skin by renewal of stratum corneum Download PDFInfo
- Publication number
- FR2780886A1 FR2780886A1 FR9808959A FR9808959A FR2780886A1 FR 2780886 A1 FR2780886 A1 FR 2780886A1 FR 9808959 A FR9808959 A FR 9808959A FR 9808959 A FR9808959 A FR 9808959A FR 2780886 A1 FR2780886 A1 FR 2780886A1
- Authority
- FR
- France
- Prior art keywords
- composition according
- composition
- acid
- vitamin
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/68—Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
Abstract
Description
La présente invention concerne une composition à usage topique, pour leThe present invention relates to a composition for topical use, for the
traitement de peaux sèches ou à tendance sèche. La couche cornée normale d'un épiderme est un pavage de cellules dont la cohésion est assurée par le cément intercornéocytaire. Le maintien de l'hydratation treatment of dry or prone to dry skin. The normal stratum corneum of an epidermis is a tiling of cells whose cohesion is ensured by the intercorneocytic cement. Maintaining hydration
cutanée dépend de l'hydrophilie des cellules épidermiques ainsi que du cément intercornéocytaire. L'hydrophilie des cellules épidermiques est liée à l'existence dans10 l'épiderme et à sa surface, de facteurs d'hydratation particuliers appelés NMF ("Natural Moisturizing Factors"). cutaneous depends on the hydrophilicity of the epidermal cells as well as on the intercorneocyte cement. The hydrophilicity of epidermal cells is linked to the existence in the epidermis and its surface, of specific hydration factors called NMF ("Natural Moisturizing Factors").
Ces agents captent l'eau du milieu extérieur vers l'intérieur des cellules épidermiques. D'autre part, le cément intercellulaire constitue une barrière lipidique15 qui contribue à la régulation du flux hydrique. Ce film est quelque fois appelé film hydrolipidique. These agents collect water from the outside to the inside of the epidermal cells. On the other hand, the intercellular cement constitutes a lipid barrier15 which contributes to the regulation of water flow. This film is sometimes called a hydrolipid film.
On trouve sur le marché de nombreuses compositions cosmétiques et/ou dermatologiques destinées à traiter les peaux sèches ou à tendance sèche. Pour ce faire, elles20 contiennent des actifs humectants tels que les polyols et des facteurs du NMF cutané tels que l'urée, l'acide There are many cosmetic and / or dermatological compositions on the market intended to treat dry or prone to dry skin. To do this, they contain humectant active ingredients such as polyols and cutaneous NMF factors such as urea, acid
pyrrolidone carboxylique, les acides aminés, les sucres, les acides alpha hydroxylés. Les filmogènes hydrophobes, tels que huiles végétales, qui freinent la déperdition25 transcutanée d'eau, sont aussi couramment utilisés dans ces compositions. carboxylic pyrrolidone, amino acids, sugars, alpha hydroxy acids. Hydrophobic film formers, such as vegetable oils, which inhibit transcutaneous water loss, are also commonly used in these compositions.
Toutes ces compositions présentent au mieux un effet hydratant limité dans le temps, car elles ne All these compositions have at best a hydrating effect limited in time, because they do not
contribuent qu'à améliorer temporairement le taux30 d'hydratation de la couche cornée de l'épiderme. help only temporarily improve the hydration rate of the stratum corneum of the epidermis.
Dans certains cas particulièrement difficiles, les compositions précitées ne permettent pas d'hydrater In certain particularly difficult cases, the above-mentioned compositions do not make it possible to hydrate
l'épiderme, voire entrainent temporairement sa déshydratation, y compris en atmosphère hydratée. the epidermis, or even temporarily cause its dehydration, including in a hydrated atmosphere.
A partir de ces constations, et à la suite d'importantes recherches, la Demanderesse a découvert que le maintien à l'état hydraté de l'épiderme dépendait en pratique du renouvellement de la couche cornée, ou stratum5 corneum, et non de l'apport d'eau fixable aux cellules From these observations, and following significant research, the Applicant has discovered that maintaining the hydrated state of the epidermis depended in practice on the renewal of the stratum corneum, or stratum5 corneum, and not on the fixable water supply to cells
épidermiques, et/ou de la mise en place d'un film occlusif. epidermal, and / or the placement of an occlusive film.
Partant de ce résultat particulièrement inattendu, la Demanderesse s'est intéressée à des compositions permettant de renouveler en profondeur le tissu épidermique. Une telle composition a alors été trouvée, pour un usage topique, dans la combinaison synergique d'au moins un céramide, d'au moins un acide gras essentiel, et d'au15 moins un composé vitaminique A. Une telle composition permet en effet un auto- entretien du cycle kératolytique, en apportant à ce On the basis of this particularly unexpected result, the Applicant is interested in compositions making it possible to renew the epidermal tissue in depth. Such a composition was then found, for topical use, in the synergistic combination of at least one ceramide, at least one essential fatty acid, and at least one vitamin A compound. Such a composition in fact allows a self-maintenance of the keratolytic cycle, bringing to this
dernier un substrat approprié. Une composition selon l'invention assure une auto- last an appropriate substrate. A composition according to the invention provides self-
régénération du tissu épidermique, par la synergie constatée sur le moyen terme, et non immédiate, entre la regeneration of the epidermal tissue, by the synergy observed in the medium term, and not immediate, between the
kératolyse d'une part, et la retructuration tissulaire épidermique, d'autre part. keratolysis on the one hand, and epidermal tissue re-structuring on the other.
Au total, avec une composition selon la présente invention, on renouvelle en permanence le tissu In total, with a composition according to the present invention, the fabric is constantly renewed
épidermique, ce qui maintient, voire améliore son organisation, tout en assurant sa fraîcheur. epidermal, which maintains or even improves its organization, while ensuring its freshness.
D'autres caractéristiques, aspects et avantages de la présente invention apparaîtront à la lecture de la Other characteristics, aspects and advantages of the present invention will appear on reading the
description détaillée qui va suivre. detailed description to follow.
Les céramides du stratum corneum sont constituées de 6 fractions, chromatographiquement distinctes, ayant une polarité différente selon leur degré d'insaturation (qui peut être nul) ou d'hydroxylation de leurs chaînes, leur longueur et leur nombre. Selon leur configuration 3 chimique, elles sont répertoriées en classe I, II, III, IV, VIa et VIb. Selon un mode particulièrement préféré, la composition selon l'invention comprend un céramide de type III, ou de type VI, en particulier avec une proportion5 pondérale comprise entre 0,001 et 5% par rapport au poids total de la composition, et de préférence comprise entre The ceramides of the stratum corneum consist of 6 fractions, chromatographically distinct, having a different polarity according to their degree of unsaturation (which can be zero) or of hydroxylation of their chains, their length and their number. According to their chemical configuration 3, they are listed in class I, II, III, IV, VIa and VIb. According to a particularly preferred embodiment, the composition according to the invention comprises a ceramide of type III, or of type VI, in particular with a proportion by weight of between 0.001 and 5% relative to the total weight of the composition, and preferably between
0,01 et 1% en poids par rapport au poids total de la composition. 0.01 and 1% by weight relative to the total weight of the composition.
L'acide gras essentiel peut être introduit dans une composition suivant l'invention, sous forme d'huile végétale, riche en acide gras essentiel, comme par exemple une huile de soja, de tournesol, de noix, de bourrache, d'onagre, de pépin de raisins. Selon un mode particulier de l'invention, l'acide gras essentiel est choisi dans le15 groupe constitué par les acides a ou y linoléniques, l'acide a linoléique, l'acide arachidonique, l'acide EPA, l'acide DHA. L'acide gras essentiel peut aussi être contenu dans un phospholipide. Selon un mode particulièrement préféré de l'invention, on utilise un20 phospholipide dans une proportion pondérale comprise entre 0,02 et 10% par rapport au poids total, et de préférence entre 0,05 et 5% en poids par rapport au poids total de la composition. Par "composé vitaminique A", on entend la vitamine The essential fatty acid can be introduced into a composition according to the invention, in the form of vegetable oil, rich in essential fatty acid, such as for example a soybean oil, sunflower oil, walnut, borage, evening primrose, of grape seed. According to a particular embodiment of the invention, the essential fatty acid is chosen from the group consisting of a or y linolenic acids, a linoleic acid, arachidonic acid, EPA acid, DHA acid. The essential fatty acid can also be contained in a phospholipid. According to a particularly preferred embodiment of the invention, a phospholipid is used in a weight proportion of between 0.02 and 10% relative to the total weight, and preferably between 0.05 and 5% by weight relative to the total weight of the composition. By "vitamin A compound" is meant vitamin
A, tout précurseur, ou tout dérivé de cette dernière. A, any precursor, or any derivative thereof.
Le composé vitaminique A utilisé dans la composition suivant la présente invention peut être choisi dans le groupe constitué par le rétinol, l'acétate de vitamine A et le palmitate de vitamine A. Selon un mode30 particulièrement préféré de la présente invention, on utilise du palmitate de vitamine A, notamment dans une proportion comprise entre 0,01 et 3% en poids par rapport au poids total de la composition, et de préférence entre 0,05 et 1% en poids par rapport au poids total de la The vitamin A compound used in the composition according to the present invention can be chosen from the group consisting of retinol, vitamin A acetate and vitamin A palmitate. According to a particularly preferred mode of the present invention, palmitate is used of vitamin A, in particular in a proportion of between 0.01 and 3% by weight relative to the total weight of the composition, and preferably between 0.05 and 1% by weight relative to the total weight of the
composition.composition.
La composition selon l'invention peut se présenter sous toutes les formes galéniques classiquement utilisées dans les compositions cosmétiques ou dermatologiques, à usage topique.5 Les compositions selon l'invention peuvent en outre contenir tous les constituants classiquement utilisés dans les compositions cosmétiques et/ou dermatologiques. Les compositions selon l'invention peuvent de plus contenir des principes actifs classiquement utilisés dans les compositions cosmétiques et/ou dermatologiques autres que les céramides, les acides gras essentiels, les composés vitaminiques A. Des exemples concrets, mais nullement limitatifs, The composition according to the invention can be in all the galenical forms conventionally used in cosmetic or dermatological compositions, for topical use. The compositions according to the invention can also contain all the constituents conventionally used in cosmetic compositions and / or dermatological. The compositions according to the invention may also contain active principles conventionally used in cosmetic and / or dermatological compositions other than ceramides, essential fatty acids, vitamin compounds A. Concrete examples, but in no way limitative,
illustrant l'invention, vont maintenant être donnés. illustrating the invention, will now be given.
Exemple 1: Stearate de sucrose 0,5-6 % Distéarate de sucrose 0,5-6 %20 Triglycéride caprylique/caprique 3-15 % Triglycéride caprylique/caprique/succinique 3-15 % Céramide III 0,05-1 % Palmitate d'ascorbyle 0,01-0,1 % Acetate de tocophéryle 0,05-1 %25 Urée 0,5-2 % Chlorure de calcium 0,05-0,5 % Chlorure de magnésium 0,05-0,5 % Sérine 0,2-2 % Glycérine 0,5-3 %30 Acide citrique 0,1-05 % Citrate trisodique 0,5-1, 5 % Palmitate de vitamine A 0,1-2 % Phospholipides 0,1-0,4 % Superoxyde dismutase 0,5-2 %35 Hyaluronate de sodium 0,5-3 % Sorbate de potassium 0,2- 0,5 % Example 1: Sucrose stearate 0.5-6% Sucrose distearate 0.5-6% 20 Caprylic / capric triglyceride 3-15% Caprylic / capric / succinic triglyceride 3-15% Ceramide III 0.05-1% Palmitate d ascorbyle 0.01-0.1% Tocopheryl acetate 0.05-1% 25 Urea 0.5-2% Calcium chloride 0.05-0.5% Magnesium chloride 0.05-0.5% Serine 0.2-2% Glycerin 0.5-3% 30 Citric acid 0.1-05% Trisodium citrate 0.5-1.5% Vitamin A palmitate 0.1-2% Phospholipids 0.1-0.4 % Superoxide dismutase 0.5-2% 35 Sodium hyaluronate 0.5-3% Potassium sorbate 0.2-0.5%
Gomme sclerotium 0,1-0,5 % Gomme xanthane 0,1-0,5 % Eau qsp.100 %5 Parfum qs. Conservateurs qs. Sclerotium gum 0.1-0.5% Xanthan gum 0.1-0.5% Water qs. 100% 5 Perfume qs. Preservatives qs.
Exemple 2:Example 2:
Phospholipides 3 % Céramide III 0,1 % Palmitate de vitamine A 0,1 à 1 % Stéareth-20 0,2 % Methylparabène 0,25 % Chlorure de calcium 0,01 %15 Chlorure de magnesium 0,01 % Eau qsp.100 % Stéareth-2 1 3 % Alcool cétyl stéarylique 2 4 % Myristate de myristyle 2 4 %20 Myristate d'isopropyle 4 % Glycérine 1% Dimethicone 0,5 % Alcools lanoliniques 0,5 % Propylparabène 0,25 %25 Exemple 3: Oléate de sorbitane 3,5 % Polysorbate 80 2 4 % Huile de germe de blé 3 %30 Huile d'amandes douces 5 % Myristate d'isopropyle 12 % Phospholipides 0,5 % Céramides III 0,1 % Polyacrylamide & C14-13 isoparaffine & laureth-7 2 3,5 % Palmitate de vitamine A 0,1 à 1 % 6 Tocopherol 0,05 % PCANa 0,5 % Hyaluronate de sodium 0,1 % Eau qsp.100 %5 Conservateurs qsp Parfum qsp Une composition selon la présente invention se caractérise en particulier par le fait qu'elle ne comprend pratiquement aucun composé actif humectant de l'épiderme, en particulier un composé filmogène hydrophile, par Phospholipids 3% Ceramide III 0.1% Vitamin A palmitate 0.1 to 1% Steareth-20 0.2% Methylparaben 0.25% Calcium chloride 0.01% 15 Magnesium chloride 0.01% Water qs. 100 % Steareth-2 1 3% Cetyl stearyl alcohol 2 4% Myristyl myristate 2 4% 20 Isopropyl myristate 4% Glycerin 1% Dimethicone 0.5% Lanolin alcohols 0.5% Propylparaben 0.25% 25 Example 3: Oleate sorbitan 3.5% Polysorbate 80 2 4% Wheat germ oil 3% 30 Sweet almond oil 5% Isopropyl myristate 12% Phospholipids 0.5% Ceramides III 0.1% Polyacrylamide & C14-13 isoparaffin & laureth-7 2 3.5% Vitamin A palmitate 0.1 to 1% 6 Tocopherol 0.05% PCANa 0.5% Sodium hyaluronate 0.1% Water qs. 100% 5 Preservatives qs Fragrance qs A composition according to the The present invention is characterized in particular by the fact that it comprises practically no active humectant compound of the epidermis, in particular a hydrophilic film-forming compound, by
exemple un collagène ou de la carboxyméthylcellulose, ou encore une substance hydroscopique, par exemple un polyol; et/ou qu'elle ne comprend pratiquement aucun15 agent filmogène hydrophobe, par exemple un silicone ou une huile végétale. for example a collagen or carboxymethylcellulose, or else a hydroscopic substance, for example a polyol; and / or that it comprises practically no hydrophobic film-forming agent, for example a silicone or a vegetable oil.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9808959A FR2780886B1 (en) | 1998-07-08 | 1998-07-08 | SELF-MOISTURIZING COMPOSITION FOR THE SKIN |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9808959A FR2780886B1 (en) | 1998-07-08 | 1998-07-08 | SELF-MOISTURIZING COMPOSITION FOR THE SKIN |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2780886A1 true FR2780886A1 (en) | 2000-01-14 |
FR2780886B1 FR2780886B1 (en) | 2001-06-29 |
Family
ID=9528581
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR9808959A Expired - Fee Related FR2780886B1 (en) | 1998-07-08 | 1998-07-08 | SELF-MOISTURIZING COMPOSITION FOR THE SKIN |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2780886B1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001008650A1 (en) * | 1999-07-30 | 2001-02-08 | Unilever Plc | Skin care composition |
WO2004073663A1 (en) * | 2003-02-18 | 2004-09-02 | Unilever Plc | Hair treatment compositions |
US7172754B1 (en) | 2005-12-23 | 2007-02-06 | Conopco, Inc. | Cosmetic emulsions with sunscreens and conjugated linoleic acid |
US7175836B1 (en) | 2005-12-23 | 2007-02-13 | Conopco, Inc. | Oil continuous phase cosmetic emulsions with conjugated linoleic acid |
US7175835B1 (en) | 2005-12-23 | 2007-02-13 | Conopco, Inc. | Cosmetic emulsions with inorganic sunscreens stabilized with conjugated linoleic acid |
US20130035395A1 (en) * | 2010-04-07 | 2013-02-07 | Fujifilm Corporation | Water-based cosmetic and manufacturing method thereof |
FR3005860A1 (en) * | 2013-05-21 | 2014-11-28 | Oreal | COMPOSITIONS COMPRISING ULKENIA OIL AND USES THEREOF FOR IMPROVING AND / OR STRENGTHENING THE BARRIER FUNCTION |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2690343A1 (en) * | 1992-04-28 | 1993-10-29 | Inocosm Laboratoires | Compsn. with anti-radical and anti-lipo-peroxidising effect contg. polar lipid - for use in cosmetics, dietetics, food industry and pharmacology |
WO1994000127A1 (en) * | 1992-06-19 | 1994-01-06 | The Regents Of The University Of California | Lipids for epidermal moisturization and repair of barrier function |
EP0646370A1 (en) * | 1993-09-30 | 1995-04-05 | Roussel Uclaf | Cosmetic and dermatological compositions containing an association of ceramides and linoleic acids, their preparation |
US5451405A (en) * | 1994-04-25 | 1995-09-19 | Chesebrough-Pond's Usa Co. | Skin treatment composition |
US5476661A (en) * | 1994-10-21 | 1995-12-19 | Elizabeth Arden Co., Division Of Conopco, Inc. | Compositions for topical application to skin, hair and nails |
EP0742005A2 (en) * | 1995-05-08 | 1996-11-13 | Unilever Plc | Skin care compositions containing fatty acid amides and retinol or retinyl ester |
US5578641A (en) * | 1993-04-20 | 1996-11-26 | Elizabeth Arden Co., Division Of Conopco, Inc. | Cosmetic composition |
US5776480A (en) * | 1994-12-14 | 1998-07-07 | L'oreal | Cosmetic or dermatological composition containing a mixture of ceramides for moisturizing the skin |
-
1998
- 1998-07-08 FR FR9808959A patent/FR2780886B1/en not_active Expired - Fee Related
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2690343A1 (en) * | 1992-04-28 | 1993-10-29 | Inocosm Laboratoires | Compsn. with anti-radical and anti-lipo-peroxidising effect contg. polar lipid - for use in cosmetics, dietetics, food industry and pharmacology |
WO1994000127A1 (en) * | 1992-06-19 | 1994-01-06 | The Regents Of The University Of California | Lipids for epidermal moisturization and repair of barrier function |
US5578641A (en) * | 1993-04-20 | 1996-11-26 | Elizabeth Arden Co., Division Of Conopco, Inc. | Cosmetic composition |
EP0646370A1 (en) * | 1993-09-30 | 1995-04-05 | Roussel Uclaf | Cosmetic and dermatological compositions containing an association of ceramides and linoleic acids, their preparation |
US5451405A (en) * | 1994-04-25 | 1995-09-19 | Chesebrough-Pond's Usa Co. | Skin treatment composition |
US5476661A (en) * | 1994-10-21 | 1995-12-19 | Elizabeth Arden Co., Division Of Conopco, Inc. | Compositions for topical application to skin, hair and nails |
US5776480A (en) * | 1994-12-14 | 1998-07-07 | L'oreal | Cosmetic or dermatological composition containing a mixture of ceramides for moisturizing the skin |
EP0742005A2 (en) * | 1995-05-08 | 1996-11-13 | Unilever Plc | Skin care compositions containing fatty acid amides and retinol or retinyl ester |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001008650A1 (en) * | 1999-07-30 | 2001-02-08 | Unilever Plc | Skin care composition |
WO2004073663A1 (en) * | 2003-02-18 | 2004-09-02 | Unilever Plc | Hair treatment compositions |
US7172754B1 (en) | 2005-12-23 | 2007-02-06 | Conopco, Inc. | Cosmetic emulsions with sunscreens and conjugated linoleic acid |
US7175836B1 (en) | 2005-12-23 | 2007-02-13 | Conopco, Inc. | Oil continuous phase cosmetic emulsions with conjugated linoleic acid |
US7175835B1 (en) | 2005-12-23 | 2007-02-13 | Conopco, Inc. | Cosmetic emulsions with inorganic sunscreens stabilized with conjugated linoleic acid |
US20130035395A1 (en) * | 2010-04-07 | 2013-02-07 | Fujifilm Corporation | Water-based cosmetic and manufacturing method thereof |
US10881600B2 (en) | 2010-04-07 | 2021-01-05 | Fujifilm Corporation | Water-based cosmetic and manufacturing method thereof |
FR3005860A1 (en) * | 2013-05-21 | 2014-11-28 | Oreal | COMPOSITIONS COMPRISING ULKENIA OIL AND USES THEREOF FOR IMPROVING AND / OR STRENGTHENING THE BARRIER FUNCTION |
Also Published As
Publication number | Publication date |
---|---|
FR2780886B1 (en) | 2001-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0747043B1 (en) | Use of salicylic acid derivatives for skin whitening | |
JPH02218602A (en) | Senile skin-treating composition | |
EP1252882B1 (en) | Process to increase the threshold tolerance of the sensitive skin | |
EP1572148B1 (en) | Cosmetic composition comprising a siegesbeckia extract and a lipopeptide | |
FR2710264A1 (en) | Use for the treatment of combination skin of an effective amount of active substances. | |
FR2810242A1 (en) | Cosmetic and/or dermatological composition for treating skin comprises essentially a cocoa extract containing polyphenols | |
CA2134623A1 (en) | Polyol-containing water in oil emulsion and its use in cosmetology | |
FR2780886A1 (en) | Topical cosmetic composition useful for treatment of dry skin by renewal of stratum corneum | |
JP2010511021A (en) | Use of gamma aminobutyric acid as a depigmenting agent. | |
FR2885050A1 (en) | Slimming cosmetic and/or pharmaceutical composition, useful for treatment of adipocytes of skin, comprises cocoa extract containing polyphenols | |
AU2002243390B2 (en) | Cholesterol sulfate and amino sugar compositions for enhancement of stratum corneum function | |
Smith | The effects of topical L (+) lactic acid and ascorbic acid on skin whitening | |
FR2723316A1 (en) | Compsn. for skin de-pigmentation caused by hyper:activation melanocytes | |
FR2782922A1 (en) | Urea-containing composition useful for skin treatment, especially moisturization, contains N-substituted amino sulfonic acid buffer | |
FR2948877A1 (en) | Topical composition, useful e.g. to protect and regenerate the skin, comprises an active complex comprising combination of plant extracts containing Alaria esculenta algae extract and Crambe maritima extract | |
EP1303253B1 (en) | Composition, in particular cosmetic, comprising dhea and/or a precursor or derivative thereof, combined with at least a glycation inhibiting agent | |
FR2939041A1 (en) | MOISTURIZING MIXTURE, COSMETIC AND / OR PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME, AND USE AND COSMETIC TREATMENT METHOD USING THE MIXTURE | |
JP2007022931A (en) | Skin-protection cosmetic product | |
FR2633516A1 (en) | Cosmetic composition for the treatment of dehydrated sensitive skins | |
WO2013098519A2 (en) | Use of a composition for preventing and combating the effects of tobacco on the skin | |
KR20000018910A (en) | Composition for acne skin | |
FR2876909A1 (en) | Cosmetic and/or pharmaceutical composition, to prevent or treat adipose overloads and cellulitis, comprises a combination of one or more xanthinic bases and chaulmoogra oil and/or its components | |
EP1311235A2 (en) | Cosmetic and/or dermatological composition with enhanced hydrating activity, comprising a crosslinked polysiloxane | |
EP1232743B1 (en) | Refreshing cosmetic and/or dermatological composition | |
CA3233323A1 (en) | Brightening compositions and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CL | Concession to grant licences | ||
CL | Concession to grant licences | ||
AU | Other action affecting the ownership or exploitation of an industrial property right | ||
PLFP | Fee payment |
Year of fee payment: 19 |
|
ST | Notification of lapse |
Effective date: 20180330 |